SSP

Changes and Expiries to Multiple SSPs

The Department of Health and Social Care (DHSC) has confirmed that there is sufficient stock of Lenzetto® 1.53mg/dose transdermal spray to meet current demands. The Serious Shortage Protocols (SSPs) for these products expired on Friday 13th January 2023, after this date, any prescriptions for Lenzetto® sprays must be dispensed in accordance with the prescription, and the SSPs will no longer be valid for use.

The expired SSPs are:

  • SSP026 Lenzetto® 1.53mg/dose spray (Restriction)
  • SSP027 Lenzetto® 1.53mg/dose spray (Substitution)
  • SSP028 Lenzetto® 1.53mg/dose spray (Restriction & Substitution)

The following SSPs have been extended to Friday 27th January 2023

SSP029 Sandrena®  0.5mg and 1mg gel sachets

SSP030 Sandrena®  0.5mg and 1mg gel sachets

SSP031 Sandrena®  0.5mg and 1mg gel sachets

SSP036 Estraderm MX® 100mcg patches

SSP038 Estraderm MX® 75mcg patches

These expiry dates may be brought forward or extended, and the content may be amended throughout this period. Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product.

More information on Serious Shortage Protocols